Works matching IS 09066705 AND DT 2022 AND VI 31 AND IP 4
Results: 24
Aryl hydrocarbon receptor/nuclear factor E2‐related factor 2 (AHR/NRF2) signalling: A novel therapeutic target for atopic dermatitis.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 4, p. 485, doi. 10.1111/exd.14541
- By:
- Publication type:
- Article
Pyoderma gangrenosum: A systematic review of the molecular characteristics of disease.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 4, p. 498, doi. 10.1111/exd.14534
- By:
- Publication type:
- Article
Spatiotemporal expression of NRAS and occurrence of giant congenital melanocytic nevi.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 4, p. 582, doi. 10.1111/exd.14527
- By:
- Publication type:
- Article
GDNF neurotrophic factor signalling determines the fate of dermal fibroblasts in wound‐induced hair neogenesis and skin regeneration.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 4, p. 577, doi. 10.1111/exd.14526
- By:
- Publication type:
- Article
Roles of cutaneous cell‐cell communication in wound healing outcome: An emphasis on keratinocyte‐fibroblast crosstalk.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 4, p. 475, doi. 10.1111/exd.14516
- By:
- Publication type:
- Article
Tranexamic acid inhibits melanogenesis partially via stimulation of TGF‐β1 expression in human epidermal keratinocytes.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 4, p. 633, doi. 10.1111/exd.14509
- By:
- Publication type:
- Article
Topical κ‐opioid receptor agonist asimadoline improves dermatitis in a canine model of atopic dermatitis.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 4, p. 628, doi. 10.1111/exd.14507
- By:
- Publication type:
- Article
An integrative multi‐omic analysis reveals a major metabolic rewiring between baby foreskin keratinocytes and adult female abdominal keratinocytes.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 4, p. 622, doi. 10.1111/exd.14503
- By:
- Publication type:
- Article
Vorinostat, a histone deacetylase inhibitor, as a potential novel treatment for psoriasis.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 4, p. 567, doi. 10.1111/exd.14502
- By:
- Publication type:
- Article
Gene expression profiling of laminin α3‐blocked keratinocytes reveals an immune‐independent mechanism of blistering.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 4, p. 615, doi. 10.1111/exd.14501
- By:
- Publication type:
- Article
IFN‐γ‐induced PD‐L1 expression on human melanocytes is impaired in vitiligo.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 4, p. 556, doi. 10.1111/exd.14500
- By:
- Publication type:
- Article
Early redox homeostasis disruption contributes to the differential cytotoxicity of imiquimod on transformed and normal endothelial cells.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 4, p. 608, doi. 10.1111/exd.14499
- By:
- Publication type:
- Article
Oral supplementation of inorganic pyrophosphate in pseudoxanthoma elasticum.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 4, p. 548, doi. 10.1111/exd.14498
- By:
- Publication type:
- Article
MicroRNA profiling of psoriatic skin identifies 11 miRNAs associated with disease severity.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 4, p. 535, doi. 10.1111/exd.14497
- By:
- Publication type:
- Article
Two novel mutations of the γ‐secretase genes in Chinese acne inversa (hidradenitis suppurativa).
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 4, p. 643, doi. 10.1111/exd.14496
- By:
- Publication type:
- Article
Evidence for a role of extracellular heat shock protein 70 in epidermolysis bullosa acquisita.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 4, p. 528, doi. 10.1111/exd.14495
- By:
- Publication type:
- Article
Do epidermal keratinocytes have sensory and information processing systems?
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 4, p. 459, doi. 10.1111/exd.14494
- By:
- Publication type:
- Article
Pathogenesis of solar urticaria: Classic perspectives and emerging concepts.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 4, p. 586, doi. 10.1111/exd.14493
- By:
- Publication type:
- Article
The 5‐HT<sub>1A</sub> receptor agonist, 8‐OH‐DPAT, attenuates long‐lasting pain in imiquimod‐induced psoriasis in mice.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 4, p. 600, doi. 10.1111/exd.14492
- By:
- Publication type:
- Article
Hyaluronan: A key player or just a bystander in skin photoaging?
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 4, p. 442, doi. 10.1111/exd.14491
- By:
- Publication type:
- Article
Erythrokeratodermia variabilis et progressiva due to a novel mutation in GJB4.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 4, p. 594, doi. 10.1111/exd.14490
- By:
- Publication type:
- Article
Engineering functional skin constructs: A quantitative comparison of three‐dimensional bioprinting with traditional methods.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 4, p. 516, doi. 10.1111/exd.14488
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 4, p. 439, doi. 10.1111/exd.14372
- Publication type:
- Article
Clinical outcome and safety profile of rituximab for the treatment of Dipeptidyl peptidase 4 inhibitors‐induced Bullous pemphigoid.
- Published in:
- Experimental Dermatology, 2022, v. 31, n. 4, p. 641, doi. 10.1111/exd.14483
- By:
- Publication type:
- Article